PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study (PE-Prove)

Boston Scientific

Status: Completed

Conditions: Coronary Heart Disease

Treatments: Device: Coronary stenting

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01148329

S2057

Details and patient eligibility

About

The goal of the PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post- Approval Surveillance Study is to evaluate real world clinical outcomes data for the PROMUS™ Element™ Coronary Stent System in unselected patients in routine clinical practice.

Enrollment: 1,010 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• According to Instructions For Use

Exclusion criteria

• Contraindications according to Instructions for Use

Trial design

1,010 participants in 1 patient group

Single arm observational study

Description:

To evaluate real world clinical outcomes data for the PROMUS™ Element™ Coronary Stent System in unselected patients in routine clinical practice

Treatment:

Device: Coronary stenting